brandy

Accelus Appoints Chris McKee as Vice President of Regulatory & Quality

New Appointment Strengthens Company’s Leadership in Regulatory Compliance and Quality Management PALM BEACH GARDENS, Fla., May 16, 2024 – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, today announced the appointment of Chris McKee as Vice President of Regulatory and Quality. With more than …

Accelus Appoints Chris McKee as Vice President of Regulatory & Quality Read More »

Accelus Welcomes New R&D and Product Management Leaders to Drive Innovation

PALM BEACH GARDENS, Fla., April 3, 2024 – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, announced today the addition of two new members to its leadership team: Rob German, Vice President of Research & Development, and Luke Perkins, Senior Director of Product Management. …

Accelus Welcomes New R&D and Product Management Leaders to Drive Innovation Read More »

Accelus President & CEO Kevin McGann to Present at LSI USA ’24 Conference

PALM BEACH GARDENS, Fla., March 5, 2024 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, announced today its participation in the prestigious LSI USA ’24 conference at the Monarch Beach Resort, Waldorf Astoria, in Dana Point, Calif. President & Chief Executive …

Accelus President & CEO Kevin McGann to Present at LSI USA ’24 Conference Read More »

Accelus Strengthens Leadership with New Board Appointments

Accelus CEO & Industry Veteran Kevin McGann and High-Performance Management Expert Bernie Haffey to Join as New Directors PALM BEACH GARDENS, Fla., February 12, 2024 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, has announced the appointment of two new members …

Accelus Strengthens Leadership with New Board Appointments Read More »

Accelus Introduces LineSider Modular-Cortical System for Posterior Fixation

Continued expansion of LineSider Spinal System portfolio offers surgeons increased visibility and versatility PALM BEACH GARDENS, Fla., January 29, 2024 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, today announced the launch of the LineSider® Modular-Cortical System. Designed for greater procedural …

Accelus Introduces LineSider Modular-Cortical System for Posterior Fixation Read More »

Accelus Announces Closing of $20 Million Debt Facility with Symbiotic Capital

Cash infusion to provide company with additional resources for accelerated growth PALM BEACH GARDENS, Fla., JANUARY 18, 2024 (GLOBE NEWSWIRE) –  Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, announced today that it has received a significant financial investment through a $20 million debt …

Accelus Announces Closing of $20 Million Debt Facility with Symbiotic Capital Read More »

Accelus Announces Renewed Focus on Pioneering Minimally Invasive Outpatient Procedures with Its Advanced Adaptive Geometry Technology

PALM BEACH GARDENS, Fla., December 7, 2023 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, today announced its latest strategic initiative: bolstering awareness and adoption of its proprietary Adaptive Geometry™ technology, showcased in its flagship FlareHawk® Interbody Fusion System, to meet …

Accelus Announces Renewed Focus on Pioneering Minimally Invasive Outpatient Procedures with Its Advanced Adaptive Geometry Technology Read More »

Accelus Sells Remi Robotic Navigation System to Alphatec and Announces Leadership Change to Drive Growth and Innovation

PALM BEACH GARDENS, Fla., April 19, 2023 (GLOBE NEWSWIRE) — Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, has announced a leadership change and reorganization, as well as the sale of its Remi® Robotic Navigation System assets to Alphatec Holdings, Inc. (Nasdaq: ATEC). …

Accelus Sells Remi Robotic Navigation System to Alphatec and Announces Leadership Change to Drive Growth and Innovation Read More »

Accelus Announces FDA 510(k) Clearance of Remi Robotic Navigation System for Use with 2D Fluoroscopy-Based Imaging System

Remi now cleared for use with most commonly used 2D and 3D imaging systems for spine surgery PALM BEACH GARDENS, Fla., March 16, 2023 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that the …

Accelus Announces FDA 510(k) Clearance of Remi Robotic Navigation System for Use with 2D Fluoroscopy-Based Imaging System Read More »

Accelus Announces FDA 510(k) Clearance for Remi Robotic Navigation System Software Update that Allows Image Acquisition with all Major 3D Imaging Systems

PALM BEACH GARDENS, Fla., November 3, 2022 (GLOBE NEWSWIRE) – Accelus, a privately held medical technology company focused on accelerating the adoption of minimally invasive surgery (MIS) as the standard of care in spine, today announced that the U.S. Food & Drug Administration (FDA) had cleared Accelus’s 510(k) application for its Remi™ Robotic Navigation System …

Accelus Announces FDA 510(k) Clearance for Remi Robotic Navigation System Software Update that Allows Image Acquisition with all Major 3D Imaging Systems Read More »